Company Filing History:
Years Active: 2007
Title: The Innovative Contributions of Jill A O'Loughlin
Introduction
Jill A O'Loughlin is a notable inventor based in Lincoln, MA (US). She has made significant strides in the field of medical treatments, particularly concerning the degradation of uremic toxins. Her work is crucial for patients suffering from renal disease and other related conditions.
Latest Patents
O'Loughlin holds a patent for "Systems and methods related to degradation of uremic toxins." This invention focuses on treating uremic toxins in vivo using enzymes or cells that can produce these enzymes. The treatment aims to reduce the blood concentration of non-protein nitrogen compounds, which is particularly beneficial for individuals with renal dysfunction, gout, or those undergoing chemotherapy. The oral delivery composition she developed is designed to deliver these enzymes to the intestines, where they can effectively interact with uremic toxins.
Career Highlights
O'Loughlin is affiliated with Brown University, where she continues her research and development in this vital area of healthcare. Her innovative approach to treating uremic toxins showcases her commitment to improving patient outcomes and advancing medical science.
Collaborations
O'Loughlin has collaborated with esteemed colleagues such as Jan Markus Bruder and Michael J Lysaght. These partnerships have further enhanced her research and contributed to the development of her patented technologies.
Conclusion
Jill A O'Loughlin's contributions to the field of medical treatment for uremic toxins highlight her innovative spirit and dedication to improving healthcare. Her work not only addresses critical health issues but also paves the way for future advancements in medical therapies.